Amelia Barcellini, Kazutoshi Murata, Giulia Fontana, Alessandro Vai, Chiara Cassani, Fabio Landoni, Laura Deborah Locati, Francesco Raspagliesi, Simona Secondino, Mattia Pecorilla, Shigeru Yamada, Noriyuki Okonogi, Ester Orlandi
INTRODUCTION: In the multidisciplinary management of oligometastatic, persistent, or recurrent (MPR) ovarian cancer, radiotherapy (RT) is becoming a more and more worthwhile treatment to potentially improve the chronicity of the disease. Particle beam RT has proved to be effective in several gynecological malignancies, but so far no data are available for ovarian cancer. MATERIAL AND METHODS: This is a real-world, retrospective, bi-institutional, single-arm study aimed to assess the effectiveness and the safety of carbon ion RT (CIRT) in this setting...
July 2024: Clinical and Translational Radiation Oncology